These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22305721)

  • 21. Detecting growth hormone abuse in athletes.
    Holt RI
    Drug Test Anal; 2009 Sep; 1(9-10):426-33. PubMed ID: 20355225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of growth hormone abuse in sport.
    Powrie JK; Bassett EE; Rosen T; Jørgensen JO; Napoli R; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH;
    Growth Horm IGF Res; 2007 Jun; 17(3):220-6. PubMed ID: 17339122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men.
    Velloso CP; Aperghis M; Godfrey R; Blazevich AJ; Bartlett C; Cowan D; Holt RI; Bouloux P; Harridge SD; Goldspink G
    Growth Horm IGF Res; 2013 Jun; 23(3):76-80. PubMed ID: 23433656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.
    Sartorio A; Agosti F; Marazzi N; Maffiuletti NA; Cella SG; Rigamonti AE; Guidetti L; Di Luigi L; Muller EE
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):487-93. PubMed ID: 15473882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse.
    Erotokritou-Mulligan I; Bassett EE; Cowan DA; Bartlett C; McHugh C; Sönksen PH; Holt RI;
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):161-8. PubMed ID: 18616716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting growth hormone abuse in athletes.
    Holt RI
    Anal Bioanal Chem; 2011 Aug; 401(2):449-62. PubMed ID: 21590497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
    Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
    Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples.
    Pichini S; Ventura R; Palmi I; di Carlo S; Bacosi A; Langohr K; Abellan R; Pascual JA; Pacifici R; Segura J; Zuccaro P
    J Pharm Biomed Anal; 2010 Dec; 53(4):1003-10. PubMed ID: 20674210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing.
    Hanley JA; Saarela O; Stephens DA; Thalabard JC
    Growth Horm IGF Res; 2014 Oct; 24(5):205-15. PubMed ID: 24973245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports.
    Voss SC; Robinson N; Alsayrafi M; Bourdon PC; Schumacher YO; Saugy M; Giraud S
    Drug Test Anal; 2014 Jun; 6(6):582-6. PubMed ID: 24827554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.
    Cowan DA; Moncrieffe DA
    Drug Test Anal; 2022 May; 14(5):808-819. PubMed ID: 34418311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests.
    Nguyen TV; Nelson AE; Howe CJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
    Clin Chem; 2008 Aug; 54(8):1268-76. PubMed ID: 18567697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes.
    Sartorio A; Jubeau M; Agosti F; Marazzi N; Rigamonti A; Müller EE; Maffiuletti NA
    J Endocrinol Invest; 2006 Mar; 29(3):237-43. PubMed ID: 16682837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes.
    Nelson AE; Meinhardt U; Hansen JL; Walker IH; Stone G; Howe CJ; Leung KC; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2213-22. PubMed ID: 18381573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detection.
    Böhning D; Liu W; Holt RI; Böhning W; Guha N; Sönksen P; Cowan D; Liang T
    Stat Methods Med Res; 2019 Mar; 28(3):928-936. PubMed ID: 29145769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone in sports: detecting the doped or duped.
    Ho KK; Nelson AE
    Horm Res Paediatr; 2011; 76 Suppl 1():84-90. PubMed ID: 21778756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical issues in implementing the marker method.
    Bassett EE; Erotokritou-Mulligan I
    Growth Horm IGF Res; 2009 Aug; 19(4):361-5. PubMed ID: 19515593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker detection of rhGH doping: an excretion study.
    Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse.
    Böhning D; Böhning W; Guha N; Cowan DA; Bartlett C; Sönksen PH; Holt RIG
    BMC Res Notes; 2018 Sep; 11(1):650. PubMed ID: 30185229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined statistical decision limits based on two GH-2000 scores for the detection of growth hormone misuse.
    Liu W; Bretz F; Böhning D; Holt RIG; Han Y; Böhning W; Guha N; Cowan DA
    Stat Methods Med Res; 2022 Aug; 31(8):1439-1448. PubMed ID: 35611962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.